Cholangiocarcinoma: Era of Immune Check-Point Inhibitors

被引：0
|
作者：
El Hag, Mohamed I. [1 ]
Wood-Trageser, Michelle [2 ]
Patel, Krishna [2 ]
Specht, Susan [2 ]
Sasatomi, Eizaburo [3 ]
Sun, Weijing [4 ]
Demetris, Anthony [5 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Presbyterian Shadyside, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Dept Pathol & Lab Med, Chapel Hill, NC USA
[4] Kansas Univ, Med Ctr, Lawrence, KS USA
[5] UPMC Montefiore, Pittsburgh, PA USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1750
引用
收藏
页码：633 / 633
页数：1
相关论文
共 50 条
  • [31] Use of check-point inhibitors in the treatment of progressive multifocal leukoencephalopathy
    Juarez-Salcedo, Luis Miguel
    Dalia, Samir
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [32] The Glycocode of the tumormicroenvironment in pancreatic cancer, a novel immune check-point
    Rodriquez, E.
    Giovanetti, E.
    van Vliet, S.
    Garcia-Vallejo, J.
    van Kooyk, Y.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1560 - 1560
  • [33] Immunotherapy targeting immune check-point(s) in brain metastases
    Di Giacomo, Anna Maria
    Valente, Monica
    Covre, Alessia
    Danielli, Riccardo
    Maio, Michele
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 : 33 - 38
  • [34] Orchestrating immune check-point blockade for cancer immunotherapy in combinations
    Luis Perez-Gracia, Jose
    Labiano, Sara
    Rodriguez-Ruiz, Maria E.
    Sanmamed, Miguel F.
    Melero, Ignacio
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2014, 27 : 89 - 97
  • [35] Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases
    Ocepek, Andreja
    [J]. RADIOLOGY AND ONCOLOGY, 2024,
  • [36] Comparison between CT scan evaluation criteria and PERCIST for evaluation of immune check-point inhibitors response
    Rossi, G.
    Genova, C.
    Morbelli, S.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Mennella, S.
    Dal Bello, M. G.
    Distefano, R.
    Bauckneht, M.
    Tagliamento, M.
    Cittadini, G.
    Merlo, D. F.
    Sambuceti, G.
    Grossi, F.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 162 - 162
  • [37] Kinase inhibitors and immune check-point blockade for the treatment of metastatic melanoma and advanced cancer: synergistic or antagonistic?
    Luke, Jason John
    Ott, Patrick Alexander
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (18) : 2457 - 2462
  • [38] Comparison between CT Scan Evaluation Criteria and PERCIST for Evaluation of Immune Check-Point Inhibitors Response
    Rossi, Giovanni
    Genova, Carlo
    Morbelli, Silvia
    Rijavec, Erka
    Barletta, Giulia
    Biello, Federica
    Maggioni, Claudia
    Mennella, Simone
    Dal Bello, Maria Giovanna
    Distefano, Roberta
    Bauckneht, Matteo
    Cittadini, Giuseppe
    Merlo, Franco
    Sambuceti, Gianmario
    Grossi, Francesco
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S401 - S402
  • [39] THE TRIPLE M THREAT OF CHECK-POINT INHIBITORS - AN EMERGING OVERLAP SYNDROME
    Mootoo, Amanda
    Masood, Ammara
    Maghsoudlou, Panayiotis
    D'Cruz, David
    [J]. RHEUMATOLOGY, 2022, 61
  • [40] Immune Check-Point Blockade as a Potential Therapeutic Strategy for Undifferentiated Malignancies
    Devereaux, Kelly
    Charville, Gregory
    Zhao, Shuchun
    Cherry, Athena
    van de Rijn, Matt
    Natkunam, Yasodha
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 456A - 456A
12345